Aliment Pharmacol Ther
- NEDUMANNIL L, Mohamedrashed M, Bohra A, Sood S, et al
Letter: The emerging role of novel capsule endoscopy systems in gastroenterology
with specific reference to small bowel Crohn's disease.
Aliment Pharmacol Ther. 2024;59:1162-1163.
- BARTH I, Stevens CL, Strokap CJ, Campmans-Kuijpers MJE, et al
Letter: Diet-microbiome interactions in inflammatory bowel disease-Navigating
towards individualised dietary strategies.
Aliment Pharmacol Ther. 2024;59:1154-1155.
- THWAITES PA, Gibson PR
Letter: The emerging role of novel capsule endoscopy systems in gastroenterology
with specific reference to small bowel Crohn's disease. Authors' reply.
Aliment Pharmacol Ther. 2024;59:1164-1165.
- SEIDELIN JB
Editorial: Time to address quality of life in our IBD treatment-IBD nurse
intervention as a key part of multimodal IBD management.
Aliment Pharmacol Ther. 2024;59:1152-1153.
- ALIU A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, et al
Review article: A practical approach to persistent gastrointestinal symptoms in
inflammatory bowel disease in remission.
Aliment Pharmacol Ther. 2024 Apr 8. doi: 10.1111/apt.17988.
BMC Gastroenterol
- HU N, Liu J, Gao X, Tang H, et al
Correction: The association between hemoglobin level and sarcopenia in Chinese
patients with Crohn's disease.
BMC Gastroenterol. 2024;24:130.
Dig Dis Sci
- VAN LINSCHOTEN RCA, Jansen FM, Pauwels RWM, Smits LJT, et al
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in
Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label
Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410.
Dis Colon Rectum
- KNOWLES JP, Church J
Normal Ileal Mucus Is Inadequate for Epithelial Protection in Ileal Pouch Mucosa.
Dis Colon Rectum. 2024;67:635-644.
Gut
- RIEDER F, Mukherjee PK, Massey WJ, Wang Y, et al
Fibrosis in IBD: from pathogenesis to therapeutic targets.
Gut. 2024;73:854-866.
Inflamm Bowel Dis
- DRYGIANNAKIS I, Kolios G, Filidou E, Bamias G, et al
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective
Tissue Remodeling in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 6:izae066. doi: 10.1093.
- KAYALI S, Fantasia S, Gaiani F, Cavallaro LG, et al
NOD2 and Crohn's Disease Clinical Practice: From Epidemiology to Diagnosis and
Therapy, Rewired.
Inflamm Bowel Dis. 2024 Apr 6:izae075. doi: 10.1093.
- IWAMA I, Yoshida M, Miyazawa A, Hara T, et al
Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset
Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 8:izae078. doi: 10.1093.
- ROWAN C, Yeaman F, Ernest-Suarez K, Martin ML, et al
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.
Inflamm Bowel Dis. 2024 Apr 9:izae076. doi: 10.1093.
- CARTIER L, Loiez A, Nachury M, Azahaf M, et al
Changes Over Time in the Lemann Index and the Inflammatory Bowel Disease
Disability Index in a Prospective Cohort of Patients With Crohn's Disease.
Inflamm Bowel Dis. 2024 Apr 10:izae073. doi: 10.1093.
- INNOCENTI T, Dragoni G
Bowel Damage and Disability in Crohn's Disease: Is it Really Two Birds with One
Stone?
Inflamm Bowel Dis. 2024 Apr 10:izae050. doi: 10.1093.
- HAWKINS RL, Zia M, Hind D, Lobo AJ, et al
Inequalities in Healthcare Access, Experience and Outcomes in Adults With
Inflammatory Bowel Disease: A Scoping Review.
Inflamm Bowel Dis. 2024 Apr 11:izae077. doi: 10.1093.
J Clin Gastroenterol
- PETROV JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al
Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory
Bowel Disease.
J Clin Gastroenterol. 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.
J Crohns Colitis
- ZADORA W, Innocenti T, Verstockt B, Meijers B, et al
Chronic kidney disease in inflammatory bowel disease, a systematic review and
meta-analysis.
J Crohns Colitis. 2024 Apr 8:jjae049. doi: 10.1093.
- TIONG HT, Fan D, Frampton C, Ananthakrishnan AN, et al
Physical Activity Is Associated With A Decreased Risk Of Developing Inflammatory
Bowel Disease: A Systematic Review And Meta-Analysis.
J Crohns Colitis. 2024 Apr 10:jjae053. doi: 10.1093.
- MOHAMEDRASHED M, Garg M, Bohra A
Advocating for Consensus: The crucial role of standardised Magnetic resonance
imaging (MRE) protocols and image quality metrics in assessment of Crohn's
disease.
J Crohns Colitis. 2024 Apr 12:jjae051. doi: 10.1093.
- PETIT P, Leroyer A, Chamot S, Fumery M, et al
Farming activities and risk of inflammatory bowel disease: a French nationwide
population-based cohort study.
J Crohns Colitis. 2024 Apr 12:jjae050. doi: 10.1093.
J Gastroenterol
- MAKUUCHI M, Kakuta Y, Umeno J, Fujii T, et al
Real-world NUDT15 genotyping and thiopurine treatment optimization in
inflammatory bowel disease: a multicenter study.
J Gastroenterol. 2024 Apr 8. doi: 10.1007/s00535-024-02099.
Lancet Gastroenterol Hepatol
- FUMERY M, Buisson A
Has the time come for a systematic top-down approach in Crohn's disease?
Lancet Gastroenterol Hepatol. 2024;9:394-395.
- BETHLEHEM L, Estevinho MM, Grinspan A, Magro F, et al
Microbiota therapeutics for inflammatory bowel disease: the way forward.
Lancet Gastroenterol Hepatol. 2024;9:476-486.
Minerva Gastroenterol (Torino)
- FANTINI MC, Onali S, Gasbarrini A, Lopetuso LR, et al
Immune system and gut microbiota senescence in elderly IBD patients.
Minerva Gastroenterol (Torino). 2024;70:59-67.
- LEONCINI G, Reggiani-Bonetti L, Simoncelli G, Villanacci V, et al
Histology of IBD and related colitides in the elderly.
Minerva Gastroenterol (Torino). 2024;70:68-78.
- CASTIGLIONE F, Imperatore N, Zingone F, D'Inca R, et al
Therapy in elderly IBD patients.
Minerva Gastroenterol (Torino). 2024;70:89-97.
- INGRASCIOTTA Y, Grova M, Crispino F, Isgro V, et al
Safety and potential interaction of immunosuppressive drugs for the treatment of
inflammatory bowel disease in elderly patients.
Minerva Gastroenterol (Torino). 2024;70:98-108.
- VIOLA A, Fiorino G, Costantino G, Fries W, et al
Epidemiology and clinical course of late onset inflammatory bowel disease.
Minerva Gastroenterol (Torino). 2024;70:52-58.
- BELLONE F, Sardella A, Muscianisi M, Basile G, et al
Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease.
Minerva Gastroenterol (Torino). 2024;70:79-88.
PLoS One
- HU J, Huang Y, Jia R, Wang X, et al
Absolute monocyte counts could predict disease activity and secondary loss of
response of patients with Crohn's disease treated with anti-TNF-alpha drug.
PLoS One. 2024;19:e0301797.
- FU W, Zhu B, Chen J, Jin X, et al
Risk relationship between inflammatory bowel disease and urolithiasis: A
two-sample Mendelian randomization study.
PLoS One. 2024;19:e0301545.
Z Gastroenterol
- SCHMIDT C, Stallmach A, Sturm A, Bachmann O, et al
[Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis:
Management of Patients with Inflammatory Bowel Disease with regard to COVID-19
(version 2.0)].
Z Gastroenterol. 2024;62:517-534.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016